[1]吴菲菲,朱端荣,周秋明,等.宫腔镜息肉切除术联合不同术后治疗方案治疗子宫内膜息肉疗效观察[J].新乡医学院学报,2020,37(3):286-290.[doi:10.7683/xxyxyxb.2020.03.021]
　WU Feifei,ZHU Duanrong,ZHOU Qiuming,et al.Effect of hysteroscopic polypectomy combined with different postoperative treatment on endometrial polyps[J].Journal of Xinxiang Medical University,2020,37(3):286-290.[doi:10.7683/xxyxyxb.2020.03.021]
点击复制

宫腔镜息肉切除术联合不同术后治疗方案治疗子宫内膜息肉疗效观察
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
37
期数:
2020年3
页码:
286-290
栏目:
临床研究
出版日期:
2020-03-12

文章信息/Info

Title:
Effect of hysteroscopic polypectomy combined with different postoperative treatment on endometrial polyps
作者:
吴菲菲1; 朱端荣2; 周秋明2; 胡玉丽2; 吴元赭2
（1.蚌埠医学院，安徽　蚌埠　233030；2.中国人民解放军东部战区总医院妇产科，江苏　南京　210002）
Author(s):
WU Feifei1; ZHU Duanrong2; ZHOU Qiuming2; HU Yuli2; WU Yuanzhe2
(1.Bengbu Medical College,Bengbu 233030,Anhui Province,China；2.Department of Obstetrics and Gynecology,General Hospital of the Eastern Theater of the Chinese People′s Liberation Army,Nanjing 210002,Jiangsu Province,China)
关键词:
子宫内膜息肉; 宫腔镜; 息肉切除术; 左炔诺孕酮宫内节育系统; 炔雌醇环丙孕酮片
Keywords:
endometrial polyps; hysteroscope; polypectomy; levonorgestrel intrauterine system; ethinylestradiol and cyproterone acetate tablets
分类号:
R713
DOI:
10.7683/xxyxyxb.2020.03.021
文献标志码:
A
摘要:
目的　探讨宫腔镜息肉切除术联合左炔诺孕酮宫内节育系统、炔雌醇环丙孕酮片治疗子宫内膜息肉（EMP）的临床效果。方法　选择2017年1月至2018年6月中国人民解放军东部战区总医院收治的180例EMP患者为研究对象，根据治疗方案将患者分为A组、B组和C组，每60例。A组患者给予宫腔镜息肉切除术，术后不予任何处理；B组患者给予宫腔镜息肉切除术联合左炔诺孕酮宫内节育系统治疗；C组患者给予宫腔镜息肉切除术联合左炔诺孕酮宫内节育系统、炔雌醇环丙孕酮片治疗。分别于术前及术后3、6、12个月进行阴道超声检查，检测子宫内膜厚度，采用月经失血图评估月经量；分别于术前及术后6、12个月检测患者血红蛋白水平；统计患者术后6、12个月EMP复发情况及阴道点滴出血情况。结果　3组患者术前子宫内膜厚度比较差异无统计学意义（P＞0.05），3组患者术后3、6、12个月子宫内膜厚度小于术前（P＜0.05）。A组患者术后6、12个月子宫内膜厚度小于术后3个月（P＜0.05），A组患者术后12个月与术后6个月子宫内膜厚度比较差异无统计学意义（P＞0.05）。B组和C组术后6、12个月子宫内膜厚度小于术后3个月，术后12个月子宫内膜厚度小于术后6个月（P＜0.05）。3组患者术后3个月子宫内膜厚度比较差异无统计学意义（P＞0.05）；术后6、12个月，B组和C组患者子宫内膜厚度小于A组（P＜0.05）；术后6个月，B组与C组患者子宫内膜厚度比较差异无统计学意义（P＞0.05）；术后12个月，C组患者子宫内膜厚度小于B组（P＜0.05）。3组患者术前血红蛋白水平比较差异无统计学意义（P＞0.05）；3组患者术后6、12个月血红蛋白水平高于术前，术后12个月血红蛋白水平高于术后6个月（P＜0.05）；术后6、12个月，B组、C组患者血红蛋白水平高于A组，C组患者血红蛋白水平高于B组（P＜0.05）。3组患者术前月经量比较差异无统计学意义（P＞0.05），3组患者术后3、6、12个月月经量少于术前（P＜0.05）；A组患者术后3、6、12个月月经量比较差异无统计学意义（P＞0.05）；B组和C组患者术后6个月月经量少于术后3个月，术后12个月月经量少于术后6个月（P＜0.05）；术后3、6个月，B组和C组患者月经量少于A组，C组患者月经量少于B组（P＜0.05）；术后12个月，B组和C组患者月经量少于A组（P＜0.05），但B组与C组患者月经量比较差异无统计学意义（P＞0.05）。术后6、12个月，B组和C组患者阴道点滴出血率、EMP复发率显著低于A组（P＜0.05），B组与C组患者EMP复发率比较差异无统计学意义（P＞0.05）；术后6个月，C组患者阴道点滴出血率低于B组（P＜0.05）；术后12个月，B组与C组患者阴道点滴出血率比较差异无统计学意义（P＞0.05）。结论　EMP患者行宫腔镜息肉切除术后予以宫腔内放置左炔诺孕酮宫内节育系统可以显著提升治疗效果，不仅可使子宫内膜明显变薄、经量明显减少，还可降低EMP复发率等的发生率；在此基础上联合口服炔雌醇环丙孕酮片则可以进一步提升疗效，降低术后早期阴道点滴出血的发生。
Abstract:
Objective　To investigate the clinical effect of hysteroscopic polypectomy combined with levonorgestrel intrauterine system and ethinylestradiol and cyproterone acetate tablets in the treatment of endometrial polyps (EMP).Methods　A total of 180 patients with EMP admitted to the General Hospital of the Eastern Theater of the Chinese People′s Liberation Army from January 2017 to June 2018 were selected as the research subjects.All the patients were divided into group A,group B and group C according to the treatment plan,with 60 patients in each group.The patients in group A were treated with hysteroscopic polypectomy without any postoperative treatment,the patients in group B were treated with hysteroscopic polypectomy combined with levonorgestrel intrauterine system,and the patients in group C were treated with hysteroscopic polypectomy combined with levonorgestrel intrauterine system and ethinylestradiol and cyproterone acetate tablets.Before and 3,6,12 months after operation,transvaginal ultrasound was performed to detect the thickness of endometrium,and the menstrual blood volume was assessed by pictorial blood loss assessment chart.The hemoglobin level was detected before and 6 and 12 months after operation.The recurrence of EMP and vaginal spotting were recorded at 6 and 12 months after operation.Results　There was no significant difference in the endometrial thickness among the three groups before operation (P>0.05).The endometrial thickness at 3,6 and 12 months after operation was less than that before operation in the three groups (P<0.05).In group A,the endometrial thickness at 6 and 12 months after operation was less than that at 3 months after operation (P<0.05),but there was no significant difference in endometrial thickness between 12 months and 6 months after operation (P>0.05).In group B and group C,the endometrial thickness at 6 and 12 months after operation was less than that at 3 months after operation,and the endometrial thickness at 12 months after operation was less than that at 6 months after operation (P<0.05).There was no significant difference in endometrial thickness among the three groups at 3 months after operation (P>0.05).The endometrial thickness in group B and group C was less than that in group A at 6 and 12 months after operation (P<0.05).There was no significant difference in endometrial thickness between group B and group C at 6 months after operation (P>0.05).The endometrial thickness in group C was less than that in group B at 12 months after operation (P<0.05).There was no significant difference in hemoglobin level among the three groups before operation(P>0.05).The hemoglobin level at 6 and 12 months after operation was higher than that before operation in the three groups,and the hemoglobin level at 12 months after operation was higher than that at 6 months after operation (P<0.05).At 6 and 12 months after operation,the hemoglobin level in group B and C was higher than that in group A,and it in group C was higher than that in group B (P<0.05).There was no significant difference in menstrual blood volume among the three groups before operation (P>0.05).The menstrual blood volume at 3,6 and 12 months after operation was less than that before operation in the three groups(P<0.05).There was no significant difference in menstrual blood volume at 3,6 and 12 months after operation in group A (P>0.05).In group B and C,the menstrual blood volume at 6 months after operation was less than that at 3 months after operation,and the menstrual blood volume at 12 months after operation was less than that at 6 months after operation (P<0.05).At 3 and 6 months after operation,the menstrual blood volume in group B and C was less than that in group A,and it in group C was less than that in group B (P<0.05).At 12 months after operation,the menstrual blood volume in group B and C was less than that in group A (P<0.05),but there was no significant difference in menstrual blood volume between group B and group C (P＞0.05).At 6 and 12 months after operation,the rates of vaginal spotting and EMP recurrence in group B and C were significantly lower than that in group A (P<0.05),but there was no significant difference in the rates of vaginal spotting and EMP recurrence between group B and group C (P>0.05).The rate of vaginal spotting in group C was lower than that in group B at 6 months after operation (P<0.05).There was no significant difference in the rate of vaginal spotting between group B and group C at 12 months after operation (P>0.05).Conclusions　Levonorgestrel intrauterine system can significantly improve the treatment effect of EMP patients after hysteroscopic polypectomy,it not only can significantly reduce the endometrium thinner and menstrual blood volume,but also can decrease the recurrence rate of EMP.On this basis,ethinylestradiol and cyproterone acetate tablet can further improve the efficacy and reduce the early rate of postoperative vaginal spotting.

参考文献/References:

［1］　曹万英，徐妃.子宫内膜息肉发生的危险因素分析［J］.中国实用医药，2019，14（12）：11-13.
［2］　李雅静，夏亲华.基于数据对子宫内膜息肉中医用药规律分析［J］.天津中医药，2018，35（3）：179-181.
［3］　蒋婴，钱旭武，张宜群，等.化瘀散结法对子宫内膜息肉患者Ki-67、Bcl-2表达的影响［J］.中国中医药科技，2018，25（1）：11-14.
［4］　吴晓杰，刘霞，金小英，等.左炔诺孕酮宫内释放系统对雌激素受体、孕激素受体及胰岛素样生长因子-1的影响［J］.中华医学杂志，2014，94（35）：2763-2765.
［5］　毛书霞，李宏波，吴意赟，等.宫腔水造影联合经阴道三维超声对子宫内膜息肉的诊断价值［J］.中国中西医结合影像学杂志，2018，16（1）：53-56.
［6］　LIENG M,ISTRE O,QVIGSTAD E.Treatment of endometrial polyps:a systematic review［J］.Acta Obstet Gynecol Scand,2010,89(8):992-1002.
［7］　尹聪，白文佩，顾蓓，等.宫腔镜直视冷刀切除绝经后子宫内膜息肉的评价［J］.中国妇幼健康研究，2018，29（1）：107-109.
［8］　冯力民，夏恩兰，黄晓武，等.应用月经失血图评估月经血量［J］.中华妇产科杂志，2001，36（1）：51.
［9］　卢美松，李萌，汤小晗，等.半胱氨酸天冬氨酸蛋白酶-8和半胱氨酸天冬氨酸蛋白酶-3在子宫内膜息肉中的表达及相关性研究［J］.中国计划生育和妇产科，2018，10（1）：19-22，36.
［10］　胡秀笼.宫腔镜子宫内膜息肉切除术后口服少腹逐瘀胶囊预防复发的疗效观察［J］.现代中西医结合杂志，2016，25（11）：1180-1182.
［11］　王瑞，蔡秋娥，汤雄文.炔诺酮联合宫腔镜子宫内膜息肉切除术治疗子宫内膜息肉的临床分析［J］.中国医学创新，2015，12（9）：141-143.
［12］　范兰玲.宫腔镜下电切术治疗子宫内膜息肉44例临床分析［J］.中国医药科学，2014，4（17）：169-171．
［13］　孙家珍，段予新，潘瑞洋，等.子宫腔灌注人绒毛膜促性腺激素对多囊卵巢综合征患者植入窗期子宫内膜容受性的影响［J］.新乡医学院学报，2019，36（7）：642-645.
［14］　景秀菊，王秀琴，王艳虹，等.宫腔镜下子宫内膜息肉切除术后口服避孕药与放置曼月乐预防复发的效果体会［J］.黑龙江医药科学，2018，41（6）：202-203.
［15］　RADOWICKA M,LEGUTOWSKA E,GAJEWSKA M,et al.Histopathological evaluation of intrauterine polyps and scrapings of the uterine cavity in women with endometrial polyp described in ultrasound［J］.Neuro Endocrinol Lett,2016,37(7):518-522.
［16］　陈筱筱，汤宝华，陈云霞.人工流产术后及月经期放置左炔诺孕酮宫内节育系统的避孕效果［J］.江苏医药，2019，45（7）：734-736.
［17］　楼俊瑶，黄秀峰，张丽凤，等.第二代子宫内膜消融术可提高左炔诺孕酮宫内节育系统对子宫腺肌病患者的疗效［J］.浙江大学学报（医学版），2019，48（2）：136-141.
［18］　司小丽，苏宝珍，杨梅枝.桂枝茯苓胶囊联合左炔诺孕酮宫内节育系统对子宫腺肌症患者子宫内膜厚度及激素水平的影响［J］.中国医院用药评价与分析，2018，18（8）：1055-1057.
［19］　覃卫玲，廖婕洁.注射用醋酸曲普瑞林联合左炔诺孕酮宫内节育系统对子宫腺肌病患者子宫血流动力学、卵巢功能及安全性的影响［J］.中国医院用药评价与分析，2019，19（5）：546-548，551.

相似文献/References:

[1]申玉红.宫腔镜联合B超检查诊断绝经后子宫出血45例[J].新乡医学院学报,2003,20(03):197.
[2]段予新,申素芳,李玉洁.宫腔镜配合超声引导下射频治疗功能失调性子宫出血[J].新乡医学院学报,2006,23(05):448.
[3]禹爱琴,刘薇,岳青芬.宫腔镜电切术治疗黏膜下子宫肌瘤83例 [J].新乡医学院学报,2007,24(02):165.
[4]李金锋.米索前列醇用于宫腔镜检查临床观察[J].新乡医学院学报,2008,25(03):272.
[5]付蕊红.宫腔镜联合腹腔镜在女性不孕症诊断及治疗中的应用[J].新乡医学院学报,2014,31(11):937.[doi:10.7683/xxyxyxb.2014.11.021]
[6]仝玉珠.宫腔镜辅助冷刀锥形切除术治疗Ⅱ、Ⅲ级宫颈上皮内瘤变疗效观察[J].新乡医学院学报,2018,35(11):1001.[doi:10.7683/xxyxyxb.2018.11.014]
　TONG Yu-zhu.Clinical effect of hysteroscopic assisted cold knife conization in treating grade Ⅱ and Ⅲ of cervical intraepithelial neoplasia[J].Journal of Xinxiang Medical University,2018,35(3):1001.[doi:10.7683/xxyxyxb.2018.11.014]
[7]寇建芳,孟跃进.宫腔镜检查联合血清人附睾分泌蛋白及糖类抗原和miR-21早期诊断子宫内膜癌的临床价值[J].新乡医学院学报,2019,36(2):185.[doi:10.7683/xxyxyxb.2019.02.022]
　KOU Jian-fang,MENG Yue-jin.Clinical value of hysteroscopy combined with serum human epididymis protein 4,carbohydrate antigen 125 and miR-21 in early diagnosis of endometrial carcinoma[J].Journal of Xinxiang Medical University,2019,36(3):185.[doi:10.7683/xxyxyxb.2019.02.022]
[8]曲　莉,郭西雨,李　蕊,等.HEOS宫腔镜与传统宫腔镜治疗宫内节育器嵌顿残留疗效比较[J].新乡医学院学报,2018,35(7):581.[doi:10.7683/xxyxyxb.2018.07.008]
　QU Li,GUO Xi-yu,LI Rui,et al.Comparison of the effect between HEOS hysteroscopy and traditional hysteroscopy in the treatment of residue and incarceration of intrauterine device[J].Journal of Xinxiang Medical University,2018,35(3):581.[doi:10.7683/xxyxyxb.2018.07.008]
[9]陈玲灵.孕三烯酮与左炔诺孕酮宫内节育系统辅助宫腔镜子宫内膜息肉切除术治疗子宫内膜息肉疗效比较[J].新乡医学院学报,2017,34(11):1012.[doi:10.7683/xxyxyxb.2017.11.015]
　CHEN Ling-ling.Comparison of the effect between gestrinone and levonorgestrel intrauterine system in the treatment of patients with endometrial polyps after transcervical resection of polyp[J].Journal of Xinxiang Medical University,2017,34(3):1012.[doi:10.7683/xxyxyxb.2017.11.015]
[10]高亮,唐璟,孙鸿展.不同手术方式治疗Ⅱ型剖宫产瘢痕妊娠临床效果比较[J].新乡医学院学报,2023,40(1):059.[doi:10.7683/xxyxyxb.2023.01.011]
　GAO Liang,TANG Jing,SUN Hongzhan.Comparison of clinical effect of different surgical methods in the treatment of type Ⅱ cesarean scar pregnancy[J].Journal of Xinxiang Medical University,2023,40(3):059.[doi:10.7683/xxyxyxb.2023.01.011]

更新日期/Last Update: 2020-03-05